Bozena Kupis-Sikora
Warsaw, MZ, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cabozantinib in the First-Line Treatment of Patients With Metastatic Renal Cell Carcinoma, Real-World Data From the Czech Republic and Poland: ICARO-RC Project.
Journal: Clinical genitourinary cancer
Published: March 06, 2025
Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients-Real-World Experience in a Single-Center Retrospective Study and Narrative Review.
Journal: Medicina (Kaunas, Lithuania)
Published: January 22, 2024
Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study.
Journal: Biomedicines
Published: January 07, 2024
Activity of cabozantinib in further line treatment of metastatic clear cell renal cell carcinoma. Real-world experience in a single-center retrospective study.
Journal: Contemporary oncology (Poznan, Poland)
Published: September 24, 2023
Prognostic value of pan-immune-inflammation value and body mass index in geriatric patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first line treatment. A single-center retrospective study.
Journal: Contemporary oncology (Poznan, Poland)
Published: January 01, 2023
First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure.
Journal: Contemporary oncology (Poznan, Poland)
Published: January 01, 2023
Contemporary treatment of metastatic renal cell carcinoma.
Journal: Medical oncology (Northwood, London, England)
Published: October 05, 2018
Prognostic factors in patients undergoing lymphadenectomy for squamous cell carcinoma of the penis.
Journal: Urologia internationalis
Published: December 20, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026